Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020194313 - TREATMENT OF HIDRADENITIS SUPPURATIVA WITH TAPINAROF COMPOSITIONS

Publication Number WO/2020/194313
Publication Date 01.10.2020
International Application No. PCT/IL2020/050369
International Filing Date 26.03.2020
IPC
A61K 31/05 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
05Phenols
A61K 31/37 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
335having oxygen as the only ring hetero atom, e.g. fungichromin
365Lactones
366having six-membered rings, e.g. delta-lactones
37Coumarins, e.g. psoralen
A61K 31/04 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
04Nitro compounds
A61P 17/10 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
17Drugs for dermatological disorders
10Anti-acne agents
Applicants
  • SOL-GEL TECHNOLOGIES LTD. [IL]/[IL]
Inventors
  • ARKIN, Moshe
Agents
  • COHEN, Mark S.
  • COHEN, Mark S.
Priority Data
62/823,88626.03.2019US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) TREATMENT OF HIDRADENITIS SUPPURATIVA WITH TAPINAROF COMPOSITIONS
(FR) TRAITEMENT DE L'HIDROSADÉNITE SUPPURÉE AVEC DES COMPOSITIONS DE TAPINAROF
Abstract
(EN)
The present invention, in some embodiments thereof, relates to treatment of hidradenitis suppurativa by topical or intralesional administration of a composition comprising tapinarof and optionally at least one additional active agent. The composition of the present invention is useful for the treatment, prevention or amelioration of hidradenitis suppurativa.
(FR)
La présente invention, dans certains modes de réalisation, concerne le traitement de l'hidrosadénite suppurée par administration topique ou intralésionnelle d'une composition comprenant du tapinarof et éventuellement au moins un agent actif supplémentaire. La composition de la présente invention est utile pour le traitement, la prévention ou le soulagement de l'hidrosadénite suppurée.
Latest bibliographic data on file with the International Bureau